Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability

Molecular Cell

Volumn 4, Issue 6, 1999, Pages 915-924

  Eliceiri, Brian P ^a   Paul, Robert ^a   Schwartzberg, Pamela L ^b   Hood, John D ^a   Leng, Jie ^a   Cheresh, David A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; FOCAL ADHESION KINASE; PROTEIN KINASE P60; PROTEIN TYROSINE KINASE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CHICKEN; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; MOUSE; NONHUMAN;

EID: 0033393771     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(00)80221-X     Document Type: Article

References (41)

1. Bett, A.J., Haddara, W., Prevec, L., and Graham, F.L. (1994). An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. USA 91, 8802-8806.
2. Brooks, P.C., Clark, R.A., and Cheresh, D.A. (1994a). Requirement of vascular integrin αVβ3 for angiogenesis. Science 264, 569-571.
3. Brooks, P.C., Montgomery, A.M., Rosenfeld, M., Reisfeld, R.A., Hu, T., Klier, G., and Cheresh, D.A. (1994b). Integrin αVβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157-1164.
4. Broome, M.A., and Hunter, T. (1996). Requirement for c-Src catalytic activity and the SH3 domain in platelet-derived growth factor BB and epidermal growth factor mitogenic signaling. J. Biol. Chem. 271, 16798-16806.
5. Bull, H.A., Brickell, P.M., and Dowd, P.M. (1994). Src-related protein tyrosine kinases are physically associated with the surface antigen CD36 in human dermal microvascular endothelial cells. FEBS Lett. 351, 41-44.
6. Chang, M.W., Barr, E., Lu, M.M., Barton, K., and Leiden, J.M. (1995). Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J. Clin. Invest. 96, 2260-2268.
7. Choi, M.E., and Ballermann, B.J. (1995). Inhibition of capillary morphogenesis and associated apoptosis by dominant negative mutant transforming growth factor-β receptors. J. Biol. Chem. 270, 21144-21150.
8. Connolly, D.T., Heuvelman, D.M., Nelson, R., Olander, J.V., Eppley, B.L., Delfino, J.J., Siegel, N.R., Leimgruber, R.M., and Feder, J. (1989). Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest. 84, 1470-1478.
9. Courtneidge, S.A., Fumagalli, S., Koegl, M., Superti-Furga, G., and Twamley-Stein, G.M. (1993). The Src family of protein tyrosine kinases: regulation and functions. Dev. Suppl., 57-64.
10. D'Amore, P.A. (1994). Mechanisms of retinal and choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 35, 3974-3979.
11. Dvorak, H.F., Brown, L.F., Detmar, M., and Dvorak, A.M. (1995). Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146, 1029-1039.
12. Eliceiri, B.P., Klemke, R., Stromblad, S., and Cheresh, D.A. (1998). Integrin αvβ3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. J. Cell. Biol. 140, 1255-1263.
13. Eriksson, E., Boykin, J.V., and Pittman, R.N. (1980). Method for in vivo microscopy of the cutaneous microcirculation of the hairless mouse ear. Microvasc. Res. 19, 374-379.
14. Folkman, J., and Shing, Y. (1992). Angiogenesis. J. Biol. Chem. 267, 10931-10934.
15. Fong, G.H., Rossant, J., Gertsenstein, M., and Breitman, M.L. (1995). Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376, 66-70.
16. Ferrara, N., and Davis-Smyth, T. (1997). The biology of vascular endothelial growth factor. Endocr. Rev. 18, 4-25.
17. Friedlander, M., Brooks, P.C., Shaffer, R.W., Kincaid, C.M., Varner, J.A., and Cheresh, D.A. (1995). Definition of two angiogenic pathways by distinct αv integrins. Science 270, 1500-1502.
18. Hughes, S.H., Greenhouse, J.J., Petropoulos, C.J., and Sutrave, P. (1987). Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors. J. Virol. 61, 3004-3012.
19. Inoue, H., Asaka, T., Nagata, N., and Koshihara, Y. (1997). Mechanism of mustard oil-induced skin inflammation in mice. Eur. J. Pharmacol. 333, 231-240.
20. Kaplan, K.B., Bibbins, K.B., Swedlow, J.R., Arnaud, M., Morgan, D.O., and Varmus, H.E. (1994). Association of the amino-terminal half of c-Src with focal adhesions alters their properties and is regulated by phosphorylation of tyrosine 527. EMBO J. 13, 4745-4756.
21. Kiefer, F., Anhauser, I., Soriano, P., Aguzzi, A., Courtneidge, S.A., and Wagner, E.F. (1994). Endothelial cell transformation by polyomavirus middle T antigen in mice lacking Src-related kinases. Curr. Biol. 4, 100-109.
22. Kim, K.J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H.S., and Ferrara, N. (1993). Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362, 841-844.
23. Klinghoffer, R.A., Sachsenmaier, C., Cooper, J.A., and Soriano, P. (1999). Src family kinases are required for integrin but not PDGFR signal transduction. EMBO J. 18, 2459-2471.
24. Meredith, J.E., Jr., Fazeli, B., and Schwartz, M.A. (1993). The extracellular matrix as a cell survival factor. Mol. Biol. Cell 4, 953-961.
25. Miles, A.A., and Miles, E.M. (1952). Vascular reactions to histamine, histamine-liberator and leukotaxine in the skin of guinea pigs. J. Physiol. 118, 228-257.
26. Miller, J.W., Adamis, A.P., Shima, D.T., D'Amore, P.A., Moulton, R.S., O'Reilly, M.S., Folkman, J., Dvorak, H.F., Brown, L.F., Berse, B., et al. (1994). Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am. J. Pathol. 145, 574-584.
27. Murohara, T., Horowitz, J.R., Silver, M., Tsurumi, Y., Chen, D., Sullivan, A., and Isner, J.M. (1998). Vascular endothelial growth factor/ vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 97, 99-107.
28. c-src. Nature 351, 69-72.
29. Passaniti, A., Taylor, R.M., Pili, R., Guo, Y., Long, P.V., Haney, J.A., Pauly, R.R., Grant, D.S., and Martin, G.R. (1992). A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest. 67, 519-528.
30. Satake, S.M., Kuzuya, M., et al. (1998). Angiogenic stimuli are essential for survival of vascular endothelial cells in three-dimensional collagen lattice. Biochem. Biophys. Res. Comm. 244, 642-646.
31. Schwartz, M.A., Schaller, M.D., and Ginsberg, M.H. (1995). Integrins: emerging paradigms of signal transduction. Annu. Rev. Cell. Dev. Biol. 11, 549-599.
32. Senger, D.R., Galli, S.J., Dvorak, A.M., Perruzzi, C.A., Harvey, V.S., and Dvorak, H.F. (1983). Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219, 983-985.
33. Shalaby, F., Rossant, J., Yamaguchi, T.P., Gertsenstein, M., Wu, X.F., Breitman, M.L., and Schuh, A.C. (1995). Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62-66.
34. Soriano, P., Montgomery, C., Geske, R., and Bradley, A. (1991). Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64, 693-702.
35. Stein, P.L., Vogel, H., and Soriano, P. (1994). Combined deficiencies of Src, Fyn, and Yes tyrosine kinases in mutant mice. Genes Dev. 8, 1999-2007.
36. Stoker, A.W., Hatier, C., and Bissell, M.J. (1990). The embryonic environment strongly attenuates v-src oncogenesis in mesenchymal and epithelial tissues, but not in endothelia. J. Cell Biol. 111, 217-228.
37. Takenaka, H., Kishimoto, S., Tooyama, I., Kimura, H., and Yasuno, H. (1997). Protein expression of fibroblast growth factor receptor-1 in keratinocytes during wound healing in rat skin. J. Invest. Dermatol. 109, 108-112.
38. Thomas, S.M., and Brugge, J.S. (1997). Cellular functions regulated by Src family kinases. Annu. Rev. Cell. Dev. Biol. 13, 513-609.
39. Twamley-Stein, G.M., Pepperkok, R., Ansorge, W., and Courtneidge, S.A. (1993). The Src family tyrosine kinases are required for platelet-derived growth factor-mediated signal transduction in NIH 3T3 cells. Proc. Natl. Acad. Sci. USA 90, 7696-7700.
40. Weidner, N., Semple, J.P., Welch, W.R., and Folkman, J. (1991). Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N. Engl. J. Med. 324, 1-8.
41. Ziche, M., Morbidelli, L., Choudhuri, R., Zhang, H.T., Donnini, S., Granger, H.J., and Bicknell, R. (1997). Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J. Clin. Invest. 99, 2625-2634.